At the end of this activity, participants should be able to recognize the different classes of antiretroviral medications and how they inhibit propagation of the virus, define and explain Highly-active Antiretroviral Therapy (HAART), identify the seven preferred regimes for treatment of naive patients, as stated by the U.S. Department of Health and Human Services, state the goals of HIV therapy and explain the importance of adherence in relation to HAART.
This continuing education activity was designed specifically for pharmacists and pharmacy technicians.
Kara Brockhaus, Pharm.D., clinical pharmacist, surgery, St. Joseph Mercy Hospital, Ann Arbor
Directions to View Activity and Receive Credit
Read the complete article and then complete the posttest and evaluation by clicking on "Add to Cart" in the right sidebar to purchase the home study course.
Please note that MPA's website is compatible with newer versions of Internet Explorer, Google Chrome, and FireFox. It is not compatible with the Safari platform.
Continuing Education Credit
Michigan Pharmacists Association (MPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Universal Activity #0112-0000-16-006-H01-P; 1.0 contact hour; Initial Release Date: 12/28/16; Expiration Date: 12/28/19
The author has indicated that she does not have any conflicts of interest, nor does she have financial relationships with a commercial interest, related to this activity.
To adequately view continuing education articles, please visit the Adobe website for the latest technical specifications for your version of Adobe Reader.
To adequately view continuing education articles, you must have Adobe Reader 6.0+. To download the latest version based on your operating system, please visit the Adobe website.
To adequately view video presentations, you must have at least a Broadband Internet connection with 500+ Kbps.
For questions regarding continuing education, please contact MPA Director of Education Mary Farrington at (517) 377-0234.